0001371285-20-000321.txt : 20201207 0001371285-20-000321.hdr.sgml : 20201207 20201207173225 ACCESSION NUMBER: 0001371285-20-000321 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201123 FILED AS OF DATE: 20201207 DATE AS OF CHANGE: 20201207 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DOAK MICHAEL CENTRAL INDEX KEY: 0001611672 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36537 FILM NUMBER: 201373652 MAIL ADDRESS: STREET 1: 907 NW BALLARD WAY CITY: SEATTLE STATE: WA ZIP: 98107 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TRUPANION, INC. CENTRAL INDEX KEY: 0001371285 STANDARD INDUSTRIAL CLASSIFICATION: HOSPITAL & MEDICAL SERVICE PLANS [6324] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6100 4TH AVENUE SOUTH STREET 2: SUITE 200 CITY: SEATTLE STATE: WA ZIP: 98108 BUSINESS PHONE: 888-733-2685 MAIL ADDRESS: STREET 1: 6100 4TH AVENUE SOUTH STREET 2: SUITE 200 CITY: SEATTLE STATE: WA ZIP: 98108 FORMER COMPANY: FORMER CONFORMED NAME: TRUPANION INC. DATE OF NAME CHANGE: 20131114 FORMER COMPANY: FORMER CONFORMED NAME: VETINSURANCE INTERNATIONAL INC DATE OF NAME CHANGE: 20060802 4 1 wf-form4_160738033246075.xml FORM 4 X0306 4 2020-11-23 0 0001371285 TRUPANION, INC. TRUP 0001611672 DOAK MICHAEL C/O TRUPANION, INC. 6100 4TH AVENUE SOUTH, SUITE 200 SEATTLE WA 98108 1 0 0 0 Common Stock 2020-01-10 5 G 0 E 5780 0 D 1578 D Common Stock 2020-01-10 5 G 0 E 5780 0 A 5780 I By Griffin Highline Holdings LLC Common Stock 2020-05-27 5 G 0 E 788 0 D 790 D Common Stock 2020-05-27 5 G 0 E 788 0 A 6568 I By Griffin Highline Holdings LLC Common Stock 2020-07-08 5 G 0 E 790 0 D 0 D Common Stock 2020-07-08 5 G 0 E 790 0 A 7358 I By Griffin Highline Holdings LLC Common Stock 2020-11-23 4 S 0 4858 96.2742 D 2500 I By Griffin Highline Holdings LLC Represents transfer of shares to a limited liability company, indirectly, wholly-owned by the reporting person. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.23 to $96.33 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2). /s/ Charlotte Sim-Warner as attorney-in-fact for Michael Doak 2020-12-07